What is the appropriate oral ivermectin dosage for treating scabies in a healthy patient weighing ≥15 kg who is not pregnant or lactating?

Ivermectin Dosage for Scabies Treatment

For scabies treatment in patients weighing ≥15 kg who are not pregnant or lactating, administer oral ivermectin 200 mcg/kg as a single dose, repeated in 7-14 days for optimal efficacy.

Dosing Regimen

The FDA-approved dosing for ivermectin (Stromectol) is 200 mcg/kg as a single oral dose 1. However, the critical point that distinguishes effective treatment from failure is administering a second dose.

Two-Dose Protocol (Recommended)

• First dose: 200 mcg/kg orally
• Second dose: 200 mcg/kg orally, given 7-14 days after the first dose
• Take on an empty stomach with water 1

This two-dose regimen is essential. A 2023 comparative study demonstrated that single-dose treatment achieved only 58% cure rates, while the two-dose regimen achieved 98% cure rates 2. The absence of a second dose is one of the main predictors of treatment failure (p < 0.001) 2.

Weight-Based Dosing Table

Based on FDA labeling 1, for 200 mcg/kg dosing:

• 15-24 kg: 1 tablet (3 mg)
• 25-35 kg: 2 tablets (6 mg)
• 36-50 kg: 3 tablets (9 mg)
• 51-65 kg: 4 tablets (12 mg)
• 66-79 kg: 5 tablets (15 mg)
• ≥80 kg: Calculate 200 mcg/kg

Evidence Supporting Two-Dose Regimen

The most recent high-quality evidence strongly favors the two-dose approach:

• A 2026 cluster randomized trial comparing ivermectin to permethrin used the two-dose protocol (days 0 and 10), though it showed permethrin superiority (88.5% vs 71.8% cure rates) 3
• A 2025 retrospective study of 360 patients found that repeated intake of ivermectin was associated with treatment success, with 78.6% overall benefit rate 4
• Another 2025 study identified that consistent second-dose administration of ivermectin was advisable for treatment success 5

Alternative Higher-Dose Consideration

Some evidence suggests 400 mcg/kg may be more effective, particularly for resistant cases:

• A 2017 study showed that a single 400 mcg/kg dose achieved complete resolution in all patients, whereas 200 mcg/kg required 2-3 doses 6
• However, this higher dose is off-label and not FDA-approved 1

Critical Safety Considerations

Contraindications:

• Children weighing <15 kg (risk of CNS toxicity due to blood-brain barrier penetration) 7
• Pregnancy and lactation (insufficient safety data)
• Patients with HIV on certain medications or those with conditions lowering seizure threshold 7

Common Adverse Effects:

• Eczematous eruptions may occur within 72 hours in up to 47.8% of patients 6
• Treat with topical corticosteroids and emollients
• Mild cutaneous reactions occur in 11.9% of patients 3
• Severe headache (rare) 8

Practical Implementation Algorithm

1. Confirm diagnosis (dermoscopy preferred for confirmation)
2. Verify patient eligibility: Weight ≥15 kg, not pregnant/lactating
3. Calculate dose: 200 mcg/kg (round to nearest tablet)
4. Administer first dose on empty stomach with water
5. Schedule second dose for 7-14 days later (10-14 days optimal) 9, 5
6. Treat all household contacts simultaneously with same regimen 3
7. Implement decontamination measures: Store clothing/bedding in plastic bags for 4 days, vacuum furniture and car seats 5
8. Reassess at day 28 for clinical cure

Common Pitfalls to Avoid

• Single-dose treatment: This is the primary cause of treatment failure 2
• Inadequate household treatment: All contacts must be treated simultaneously 3
• Insufficient decontamination: Environmental measures significantly impact success 5
• Using in children <15 kg: Risk of neurotoxicity 7
• Misinterpreting post-treatment eczema: This is a known adverse effect, not treatment failure 6

Comparative Effectiveness Note

While ivermectin is highly effective and convenient, the most recent 2026 cluster RCT showed 5% permethrin cream (applied days 0 and 10) was statistically superior to ivermectin (88.5% vs 71.8% cure rates) 3. However, ivermectin remains preferred for:

• Large populations or institutional outbreaks
• Patients non-adherent to topical therapy
• Crusted scabies (often requires higher/more frequent dosing)
• Cases resistant to topical treatments (81.36% of such patients benefited from ivermectin) 4